ResMed
711 hedge funds and large institutions have $16.4B invested in ResMed in 2024 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 293 increasing their positions, 212 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
711
Holders Change
+31
Holders Change %
+4.56%
% of All Funds
10.31%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
98
Increased
293
Reduced
212
Closed
60
Calls
$213M
Puts
$384M
Net Calls
-$172M
Net Calls Change
-$119M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
$755M |
| 2 |
JPMorgan Chase & Co
New York
|
$248M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
$98.8M |
| 4 |
Goldman Sachs
New York
|
$186M |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
$57.2M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$384M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$320M |
| 3 |
Jane Street
New York
|
$16.7M |
| 4 |
Two Sigma Advisers
New York
|
$1.19M |
| 5 |
Millennium Management
New York
|
$9.36M |
